Abstract:The nutritional status is an important factor contributing to non-relapse mortality for patients undergoing allogeneic hematopoietic stem cell transplantation (alloHSCT). In contrast to underweight, the role of overweight and obesity for alloHSCT outcomes is less well understood. This might be due to the use of the body-mass-index (BMI) as a classic measure of metabolic risk, which does not necessarily reflect body composition and visceral obesity. Importantly increased inflammation and malnutrition (Glasgow-Prognosis-Score, GPS) as well as increased neutrophil-to-lymphocyte ratios (NLR) have been described as adverse prognostic factors for a variety of solid tumors. In alloHSCT the GPS and NLR are ill defined so far. Here, we analyzed the impact of pretransplant GPS and d+100 NLR in correlation to the BMI on clinical outcomes following alloHSCT.Clinical data of consecutively treated patients between 2012 and 2017 at our transplant center were analyzed. From these cases only matched (10/10) related and unrelated donors and reduced intensity conditionings were included into the analysis. Based on BMI and GPS prior to conditioning we defined three groups respectively: normal weight (NW), overweight (OW), obese (OB); and GPS 0 (CRP<10 mg/dl, normal protein), GPS 1 (CRP >10 mg/dl, normal protein), GPS 2 (CRP >10 mg/dl, low protein). NLR at d+100 were also analyzed. We focused on survival and mortality until the data lock. Incidence rates of acute graft-versus-host disease (aGvHD) were determined until day+100.From a total of 464 identified records, 265 cases were included into the analysis based on the inclusion criteria. Median overall survival in OB patients was doubled compared to NW (48 vs. 21.8 months; p=0.01) and in OW patients median overall survival was not reached (figure 1, not included in the submitted abstract). Pretransplant GPS could also dissect survival curves with worst OS for patients with GPS 2: 9 (GPS 2) vs. 25.6 (GPS 1) vs. 48 (GPS 0) months, p=0.007). However, GPS values did not correlate with BMI (figure 2, not included in the submitted abstract).Abstract P01.18 Figure 1Abstract P01.18 Figure 2Increased d+100 NLR correlated non-significantly with poorer survival and increased relapse rates. There was a trend to increased clinically relevant aGvHD (≥II°) in GPS 2 individuals, not detectable according to BMI groupings.There is a need for better immunometabolic risk measures in patients before alloHSCT. Our data suggest that pretransplant GPS and NLR could be of value for risk estimations and further validation is warranted.K. Althoff: None. S. Leitzke: None. C. Herling: None. L. Frenzel: None. M. Herling: None. U. Holtick: None. C. Scheid: None. M. von Bergwelt-Baildon: None. S. Theurich: None.

Association of the pre-transplant CD4/CD8 ratio with the prognosis following allogeneic hematopoietic stem cell transplantation

High CD4/CD8 ratio in allografts predicts adverse outcomes in unmanipulated HLA-mismatched/haploidentical hematopoietic stem cell transplantation for chronic myeloid leukemia

[Prognostic Implications of Hematopoietic Cell Transplantation-Specific Comorbidity Index on Non-Relapse Mortality and Overall Survival after Allogeneic Hematopoietic Stem Cell Transplantation].

Superiority of BM over PBSC for recipients with pre-transplant lung dysfunction in HLA-matched allogeneic HCT

Prognostic factors in haploidentical transplantation with posttransplant cyclophosphamide for acute myeloid leukemia

Impact of Pre-Transplantation Characteristics on the Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Hematological Malignancies: a Retrospective Analysis of 100 Cases

The Impact of Graft Composition on Clinical Outcomes in Pediatric Patients Undergoing Unmanipulated Hla-Mismatched/Haploidentical Hematopoietic Stem Cell Transplantation

Prognostic impact of the conditioning intensity on outcomes after allogeneic transplantation for MDS with low blasts: a nationwide retrospective study by the adult MDS working group of the Japan Society for Transplantation and Cellular Therapy

Rapid Recovery Of Cd3(+)Cd8(+) T Cells On Day 90 Predicts Superior Survival After Unmanipulated Haploidentical Blood And Marrow Transplantation

A new multi-factor risk score system for predicting the outcome after allogenic hematopoietic stem cell transplantation]

Community health status and outcomes after allogeneic hematopoietic cell transplantation in the United States

Graft CD8 T‐cell‐based risk system predicts survival in antithymocyte globulin‐based myeloablative haploidentical peripheral blood stem cell transplantation

The Composite Immune Risk Score Predicts Overall Survival after Allogeneic Hematopoietic Stem Cell Transplantation: A Retrospective Analysis of 1838 Cases

Optimizing Timing and Preparation for Allogeneic Hematopoietic Stem Cell Transplantation in Higher-Risk Myelodysplastic Syndromes

P01.18 Metabolic status and immune activation influence clinical outcomes in patients after allogeneic hematopoietic stem cell transplantation

Prognostic significance of EBMT score system for hematological malignancies with allogeneic hematopoietic stem cell transplantation

Analysis of non-relapse mortality and causes of death over 15 years following allogeneic hematopoietic stem cell transplantation

Outcomes of allogeneic hematopoietic stem cell transplantation for relapsed or refractory diffuse large B-cell lymphoma

[Association of the Ratio of Regulatory and Effector T Cells with Recurrence and Chronic Graft-Versus-host Disease after Allogeneic Hematopoietic Stem Cell Transplantation].

Relation of Reinfused Hematopoietic Stem Cell Volume and Recipient's Leukocyte Count at Reinfusion with Prognosis of Disease in Allo-Hematopoietic Stem Cell Transplantation